Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

[Usefulness of electronic drug registers: Spanish register of patients treated with fingolimod (Gilenya ®)].
Birth Outcomes in Newborns Fathered by Men with Multiple Sclerosis Exposed to Disease-Modifying Drugs.
Gender and the hygiene hypothesis.
Association between use of interferon beta and progression of disability in patients with relapsing-remitting multiple sclerosis.
National MS Society: Sylvia Lawry Physician Fellowships
Cerebrospinal fluid data compilation and knowledge-based interpretation of bacterial, viral, parasitic, oncological, chronic inflammatory and demyelinating diseases. Diagnostic patterns not to be missed in neurology and psychiatry.
GlaxoSmithKline Protocol Summaries: Firategrast
The natural history of primary progressive MS in British Columbia, Canada.
Neuroprotective effects of testosterone treatment in men with multiple sclerosis.
Clinical Trials
Immunoregulatory T cells in multiple sclerosis and the effect of interferon beta and glatiramer acetate treatment on T cell subpopulations.
Sex ratio of multiple sclerosis and clinical phenotype.
The relevance of animal models in multiple sclerosis research.
Gender differences in 1,25 dihydroxyvitamin D3 immunomodulatory effects in multiple sclerosis patients and healthy subjects.
Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECTION): a multicentre, randomised, double-blind extension trial.
Clinically isolated syndrome - Rethinking the diagnosis.
Synthetic Biologics Reports UCLA Announcement of Preliminary Positive Topline Efficacy and Safety Results from Investigator-Led Phase II Study of Trimesta™ for RRMS
IL-17 and Th17 Cells.
Therapeutic plasma exchange and pregnancy: A case report and guidelines for performing plasma exchange in a pregnant patient.
Vitamin D and disease activity in multiple sclerosis before and during interferon-β treatment.
Comparison of Switch to Fingolimod or Interferon Beta/Glatiramer Acetate in Active Multiple Sclerosis.
The neuroendocrine axis in patients with multiple sclerosis.
Granulocyte macrophage colony-stimulating factor: a new putative therapeutic target in multiple sclerosis.
Regulatory CD4(+) T cells expressing endogenous T cell receptor chains protect myelin basic protein-specific transgenic mice from spontaneous autoimmune encephalomyelitis.
Estrogen controls vitamin D3-mediated resistance to experimental autoimmune encephalomyelitis by controlling vitamin D3 metabolism and receptor expression.

Pages